BATTEN DISEASE, MEMBRANE LIPIDS AND SIGNAL TRANSDUCTION
BATTEN DISEASE, MEMBRANE LIPIDS AND SIGNAL TRANSDUCTION
批准号:
3417103
负责人:
Michael Bennett
金额:
$11.18万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-07 至 1995-09-06
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long-term objective of this research is to elucidate the primary
biochemical and molecular defect that results in Juvenile Neuronal
Ceroid-Lipofuscinosis (JNCL, Batten disease, Spielmeyer-Vogt-Sjogren
disease).
The NCL's are a group of severe untreatable inherited neurodegenerative
diseases for which the basic defects remain unknown. Originally
classified as a common group of disorders, recent molecular studies have
demonstrated heterogeneity. This project will focus studies upon a
homogeneous cohort of patients with JNCL, defined by linkage studies of
the disease to chromosome 16, in whom we have documented a severe
deficiency of circulating erythrocyte and platelet membrane
phospholipids.
We have developed a model, based upon cultured skin fibroblasts to study
membrane phospholipids and phospholipid-dependant membrane functions. We
will present preliminary data and outline further experiments to confirm
that cultured cells express the disease process both in terms of abnormal
accumulation of storage material and membrane phospholipid deficiency.
We propose to use this model to study the effects of in vitro
perturbations with polyunsaturated fatty acids (PUFA's) as there is
growing in vivo evidence to suggest that PUFA supplementation is
clinically beneficial in JNCL and its animal, model canine NCL.
We will use our model to probe important phospholipid-dependant membrane
functions with particular reference to signal transduction and the
activities and genetic expression of the protein kinase C (PKC) gene
families. The PKC's are an important enzymes in the regulation of signal
transduction. These are highly dependant upon, and may regulate, normal
membrane phospholipid remodeling processes. We will present preliminary
evidence and a research strategy to demonstrate a failure of PKC membrane
translocation in our JNCL fibroblast cell lines, and propose that a
defect in PKC may be the primary defect in JNCL.
We will also present a strategy to evaluate a PKC gene family residing on
chromosome 16 (within the region linked to the JNCL gene) and to test the
hypothesis that a mutation affecting a novel PKC isozyme is a candidate
gene for JNCL.
Knowledge of the biochemical and molecular cause of JNCL will allow us to
develop new strategies for diagnosis and treatment. The studies will
provide more fundamental information regarding the function and
metabolism of PKC and membrane phospholipids.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-canonical mechanisms of excitotoxicity
-
批准号:10679904
-
项目类别:
-
资助金额:$3.96万
-
财政年份:2023
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:6376235
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2000
-
负责人:Michael Bennett
-
依托单位:
PATHOLOGY UTSWMC
-
批准号:6340695
-
项目类别:
-
资助金额:$12.43万
-
财政年份:2000
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:6633105
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2000
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:6131639
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2000
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:6512815
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2000
-
负责人:Michael Bennett
-
依托单位:
INTERNATIONAL CONFERENCE ON THE CEROID-LIOPFUSCINOSES
-
批准号:2723292
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1998
-
负责人:Michael Bennett
-
依托单位:
TOLERANCE TO BONE MARROW TRANSPLANTS
-
批准号:6100018
-
项目类别:
-
资助金额:$16.25万
-
财政年份:1998
-
负责人:Michael Bennett
-
依托单位:
TOLERANCE TO BONE MARROW TRANSPLANTS
-
批准号:6235437
-
项目类别:
-
资助金额:$15.62万
-
财政年份:1997
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:2390914
-
项目类别:
-
资助金额:$18.3万
-
财政年份:1996
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:2114084
-
项目类别:
-
资助金额:$17.78万
-
财政年份:1996
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:2683639
-
项目类别:
-
资助金额:$18.84万
-
财政年份:1996
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:2895496
-
项目类别:
-
资助金额:$19.37万
-
财政年份:1996
-
负责人:Michael Bennett
-
依托单位:
PATHOLOGY UTSWMC
-
批准号:6212451
-
项目类别:
-
资助金额:$12.43万
-
财政年份:1995
-
负责人:Michael Bennett
-
依托单位:
BATTEN DISEASE, MEMBRANE LIPIDS AND SIGNAL TRANSDUCTION
-
批准号:3417105
-
项目类别:
-
资助金额:$8.03万
-
财政年份:1992
-
负责人:Michael Bennett
-
依托单位:
BATTEN DISEASE, MEMBRANE LIPIDS AND SIGNAL TRANSDUCTION
-
批准号:2268225
-
项目类别:
-
资助金额:$8.92万
-
财政年份:1992
-
负责人:Michael Bennett
-
依托单位:
IMMUNOGENETICS OF HYBRID RESISTANCE
-
批准号:2089197
-
项目类别:
-
资助金额:$25.77万
-
财政年份:1984
-
负责人:Michael Bennett
-
依托单位:
IMMUNOBIOLOGY OF HYBRID RESISTANCE
-
批准号:2089200
-
项目类别:
-
资助金额:$19.26万
-
财政年份:1984
-
负责人:Michael Bennett
-
依托单位:
IMMUNOGENETICS OF HYBRID RESISTANCE
-
批准号:3174577
-
项目类别:
-
资助金额:$8.79万
-
财政年份:1984
-
负责人:Michael Bennett
-
依托单位:
IMMUNOGENETICS OF HYBRID RESISTANCE
-
批准号:3174580
-
项目类别:
-
资助金额:$27.11万
-
财政年份:1984
-
负责人:Michael Bennett
-
依托单位:
海外基金